Dynavax Technologies Corp (DVAX)
11.00
-0.64
(-5.54%)
USD |
NASDAQ |
May 09, 16:00
11.00
0.00 (0.00%)
After-Hours: 20:00
Dynavax Technologies Gross Profit (TTM): 182.12M for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 182.12M |
September 30, 2023 | 242.21M |
June 30, 2023 | 292.33M |
March 31, 2023 | 418.71M |
December 31, 2022 | 460.53M |
September 30, 2022 | 474.58M |
June 30, 2022 | 416.36M |
March 31, 2022 | 281.19M |
December 31, 2021 | 265.87M |
September 30, 2021 | 160.30M |
June 30, 2021 | 121.51M |
March 31, 2021 | 85.08M |
December 31, 2020 | 32.64M |
September 30, 2020 | 22.99M |
June 30, 2020 | 18.03M |
March 31, 2020 | 20.40M |
December 31, 2019 | 15.83M |
September 30, 2019 | 11.36M |
June 30, 2019 | 0.643M |
March 31, 2019 | -9.441M |
December 31, 2018 | -13.60M |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
0.643M
Minimum
Jun 2019
474.58M
Maximum
Sep 2022
185.41M
Average
160.30M
Median
Sep 2021
Gross Profit (TTM) Benchmarks
Supernus Pharmaceuticals Inc | 523.74M |
Esperion Therapeutics Inc | 73.07M |
Deciphera Pharmaceuticals Inc | 159.62M |
Ligand Pharmaceuticals Inc | 108.64M |
Pacira BioSciences Inc | 498.69M |